Stay updated on Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3, indicating a new version of the page.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page revision tag changes from v3.6.2 to v3.6.3, reflecting a small template update. It does not alter the study details or how information is presented to users.SummaryDifference0.1%

- Check38 days agoChange DetectedA new page revision label, v3.6.2, has been added. The previous revision label, v3.6.0, was removed, indicating an update to the page content.SummaryDifference0.1%

- Check53 days agoChange DetectedA recruitment status notice 'No longer looking for participants' was added, indicating the study is not enrolling. New help and navigation items—'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'—were added, and the 'Intervention / Treatment' heading was reformatted to 'Intervention/Treatment' while the old 'Revision: v3.5.5' note was removed in favor of 'Revision: v3.6.0'.SummaryDifference0.4%

- Check60 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, signaling a minor update to the study record display.SummaryDifference0.1%

- Check81 days agoChange DetectedThe revision label at the bottom of the page changes from Revision: v3.5.3 to Revision: v3.5.4, indicating a minor update to the page’s version history rather than updates to study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Locally Advanced Esophageal Adenocarcinoma Clinical Trial page.